Medspeak by CMJ

Can better approaches for suppressing gastric acid improve outcomes in patients with Helicobacter pylori infection? In this episode, Dr. Zhiqiang Song from the Department of Gastroenterology, Peking University Third Hospital, China, explains how potassium-competitive acid blockers (P-CABs)—therapeutics capable of more sustained gastric acid suppression compared to proton pump inhibitors (PPI)—may represent the future of standard care for H. pylori infection. A nationwide Phase III trial compa...

What makes some stroke cases more severe than others, and what can be done to improve outcomes? In this episode of Medspeak by the Chinese Medical Journal, Dr. Wu Simiao and Dr. Craig S. Anderson discuss their recent study on severe acute ischemic stroke. Drawing on data from over 4,000 patients in China, they explore why some people with stroke decline quickly, which treatments show the most promise, and how hospitals can better support recovery in patients at high-risk. This podcast, ...

Will the humanized monoclonal antibody CM310 transform treatment outcomes for patients with atopic dermatitis? In this episode, we speak with Dr. Jianzhong Zhang, Professor at Peking University People’s Hospital, who introduces a breakthrough drug for atopic dermatitis called CM310 and discusses its potential to improve the quality of life for patients living with this chronic skin condition. In 2024, Dr. Zhang and his collaborators published the results of a pivotal clinical tri...

Can cardiovascular health (CVH) assessment based on Life’s Essential 8 framework help prevent non-communicable diseases? In this episode, we speak with Dr. Ningjian Wang, Professor at the School of Medicine, Shanghai Jiao Tong University, who explains the American Heart Association’s cardiovascular health framework called ‘Life’s Essential 8’ and its association with the risk of non-communicable chronic diseases (NCDs). The potential role of Life’s Essential 8 in preventing NCDs and p...